首页> 外文期刊>ChemMedChem >Synthesis,Cruzain Docking,and in vitro Studies of Aryl-4-Oxothiazolylhydrazones Against Trypanosoma cruzi
【24h】

Synthesis,Cruzain Docking,and in vitro Studies of Aryl-4-Oxothiazolylhydrazones Against Trypanosoma cruzi

机译:克鲁氏锥虫的芳基-4-氧噻唑甲酰肼的合成,克鲁赞对接及体外研究

获取原文
获取原文并翻译 | 示例
           

摘要

Research in recent years has demonstrated that the Trypanosoma cruzi cysteine protease cruzain(TCC)is a valid chemothera-peutic target.Herein we describe a small library of aryl-4-oxothia-zolylhydrazones that have been tested in assays against T.cruzi cell cultures.The docking studies carried out suggest that these compounds are potential ligands for the TCC enzyme.The most promising compound of this series,N-(4-oxo-5-ethyl-2'-thiazolin-2-yl)-N'-phenylthio-(Z)-ethylidenehydrazone(6 f),was shown to be very active at non-cytotoxic concentrations in in vitro assays with mammalian cells and has a potency comparable with reference drugs such as nifurtimox(Nfx)and benznidazole(Bdz).
机译:近年来的研究表明,锥虫锥虫半胱氨酸蛋白酶Cruzain(TCC)是有效的化学治疗靶标。在此,我们描述了一个小型的-4-氧杂环丁烷-偶氮hydr唑烷文库,已在针对T.cruzi细胞培养的实验中进行了测试对接研究表明,这些化合物是TCC酶的潜在配体。该系列最有前途的化合物N-(4-氧代-5-乙基-2'-噻唑啉-2-基)-N'-苯硫基-(Z)-亚乙基hydr(6 f)在哺乳动物细胞的体外测定中显示出在非细胞毒性浓度下非常活跃的活性,并且具有与尼呋替莫斯(Nfx)和苯并咪唑(Bdz)等参考药物相当的功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号